NEWSWIRETODAY Press Release& Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Written by / Agency / Source: Plexus Ventures, LLC
Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Marie A. Lindner, M.D. joins Plexus Ventures LLC - Plexus Ventures, an entrepreneurial global pharmaceutical business development firm, is pleased to welcome Marie A. Lindner, M.D. as Senior Consultant and a member of the Plexus team
Marie A. Lindner, M.D. joins Plexus Ventures LLC

 

NewswireToday - /newswire/ - Santa Monica, CA, United States, 2007/04/25 - Plexus Ventures, an entrepreneurial global pharmaceutical business development firm, is pleased to welcome Marie A. Lindner, M.D. as Senior Consultant and a member of the Plexus team.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Plexus Ventures, an entrepreneurial global pharmaceutical business development firm, is pleased to welcome Marie A. Lindner, M.D. as Senior Consultant and a member of the Plexus team. Dr. Lindner brings an array of new and complementary skills and experience to Plexus in clinical development, regulatory affairs, business development, manufacturing and process development, intellectual property management and global operations. Dr. Lindner has extensive experience with development-stage companies (Isolagen, Orphagenix and Embera NeuroTherapeutics), a technology transfer firm (BTG International) and with global pharmaceutical firms (SmithKline Beecham and Rhône-Poulenc Rorer).

“We’re delighted to welcome Dr. Marie Lindner to the Plexus team,” noted Plexus Ventures President, Bob Moran. “Marie has the clinician’s perspective we were lacking as well as a wonderful experience in both the biotech and pharmaceutical industries. Dr. Lindner also possesses significant business development experience and expertise.”

Marie Lindner earned her medical degree at the Chicago Medical School/University of Health Sciences. She is Board Certified in Clinical Nutrition and Internal Medicine. From 1991 through 1998, Dr. Lindner worked at Rhone-Poulenc Rorer (now Sanofi-Aventis) where she held many positions ranging from Assistant Director of Clinical Development to Executive Director, Business Development and Licensing. During her time at RPR, Marie spent four years at Gencell, RPR's gene and cell therapy division. In 1998, Dr. Lindner joined SmithKlineBeecham (now GlaxoSmithKline) where she served as Global Director of Business Development. In 2000, Dr. Lindner joined Elan as Vice President of Medical Market Strategy in the Drug Delivery division. She was named Vice President, Strategic Business Development at BTG in 2003. In recent years, Dr. Lindner’s entrepreneurial skills have benefited development-stage companies.

About Plexus Ventures, LLC

Plexus Ventures (plexusventures.com), founded in 1990, provides strategic advice, business development and alliance management services to clients in the pharmaceutical, biotechnology and drug delivery industries worldwide. Plexus Ventures assists its clients in the areas of in-licensing, out-licensing, acquisitions, divestitures and strategic partnerships. With offices in London, Los Angeles, Milan, Philadelphia, Tokyo and Warsaw, Plexus Ventures possesses the capabilities to effectively serve clients in the United States, Europe and Asia. Plexus Ventures is both well-known and well respected by leading research-based pharmaceutical companies worldwide.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Plexus Ventures, LLC

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Marie A. Lindner, M.D. joins Plexus Ventures LLC

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
Publisher Contact: Mary Alice Strong - PlexusVentures.com 
310-315-7106 mas[.]plexusventures.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Plexus Ventures, LLC securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Plexus Ventures, LLC / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

Celltrion Pharm Selects TrackWise QMS for Scalability and Data Integrity
Ipsen Adds Another Program into its Pre-clinical R&D Oncology Pipeline through An Exclusive Worldwide Collaboration with Accent Therapeutics
Evaxion Biotech Lauded by Frost & Sullivan for Helping Develop Highly Targeted Therapies with its AI Immunology Platforms
Kyowa Hakko Acclaimed by Frost & Sullivan for its Non-GMO, Allergen-free, Immune Support Paraprobiotic Ingredient, IMMUSE™
DSM to Acquire First Choice Ingredients to Accelerate Growth in Food and Beverage
STEMCELL Technologies Launches Human Pluripotent Stem Cell Characterization and Banking Services in Partnership with WiCell
Biocon Selects TrackWise to Enable Enterprise Quality Management Across Global Biopharmaceutical Operations
STEMCELL Technologies and Hubrecht Organoid Technology to Partner on Non-Oncology Organoid Drug Screening Services
Ipsen and Exicure Enter into Exclusive Collaboration Targeting Rare Neurodegenerative Disorders
Ipsen Strengthens its Pre-clinical Oncology Pipeline with An Exclusive Worldwide-collaboration with BAKX Therapeutics, Inc. for BKX-001
Pharma and Biotech to Highly Invest in RNA Therapeutics to Expedite Research & Development across the Globe Finds Frost & Sullivan
Parexel Commended by Frost & Sullivan for Developing a Flexible and Agile Delivery Model to Improve Clinical Trial Outcome
Ipsen and IRLAB Enter Exclusive Worldwide Licensing Agreement Aimed to Improve the Lives of People Living with Parkinson’s Disease
Exelixis and Ipsen Announce Cabozantinib in Combination with An Immune Checkpoint Inhibitor Significantly Improved Progression
Ipsen Opts-in to Join Exelixis with Ongoing Development of Cabometyx® for People Living with A Form of Thyroid Cancer

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Limelon Advertising, Co.

Visit  BizJobs.com





 
  ©2021 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)